Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$250k
2 rounds on record
Latest round
$100k
Venture round · Jan 2024 · 2 yr ago
Team
11-50
employees, estimated range
The money's age
Long since its last round
33 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jan 15, 2024 Raised a round Venture round $100k · SEC Form D Nov 17, 2020 Raised a round Venture round $150k · SEC Form D 2019 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jan 2024 $100k — SEC Form D
Venture round Nov 2020 $150k — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Dome Therapeutics, LLC SEC Form D
Founders and leadersfrom filings, registers and the company's site
Jordan GreenExecutive Officer, DirectorSEC Form D
Alfredo Quinones-HinojosaExecutive OfficerSEC Form D
Kyung-Soo LiewExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
bit.bioVenture round · 6 mo ago • Founded 2016 • 11-50 employees
With our opti-ox™ technology, we precisely, consistently, & efficiently reprogram stem cells into any cell type at scale for your research…
VetbiolixFounded 2018 • 1-10 employees
Vetbiolix is a veterinary biotech developing first-in-class therapeutics for pets. Targeting Osteoarthritis, Periodontitis & Gut Motility…
ConceptionVenture round $50k · 2 yr ago • Founded 2018 • 11-50 employees • 4 roles
Conception combines stem cell biology and engineering to create new possibilities for having children.
Tavra BiosciencesVenture round $300k · 6 mo ago • Founded 2026 • 11-50 employees
Explore stem cells and regenerative medicine. Learn about mCELL™, published research, and resources for patients and physicians.
Imagine a brighter future. Geneus Biotech is committed to reducing intensive animal farming, waste and pollution through a unique patented…
Syntax BioSeries A · 3 mo ago • 51-200 employees
Syntax Bio is a synthetic biology company programming the next generation of stem cell-derived therapies and organoids.

Overview

Dome Therapeutics is a preclinical biotech developing a nanomedicine that targets the brain cancer stem cells behind glioblastoma recurrence.

People

Jordan Green
Executive Officer, Director
Alfredo Quinones-Hinojosa
Executive Officer
Kyung-Soo Liew
Executive Officer
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Financials

Total raised
$250k
Latest round
Venture - Series Unknown
Funding rounds
2
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $100k Details
Venture - Series Unknown 2020 $150k Details